questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Composés benzhydryliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Gene Expression Profiling
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques : Questions médicales les plus fréquentes",
"headline": "Composés benzhydryliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés benzhydryliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diphénhydramine",
"alternateName": "Diphenhydramine",
"url": "https://questionsmedicales.fr/mesh/D004155",
"about": {
"@type": "MedicalCondition",
"name": "Diphénhydramine",
"code": {
"@type": "MedicalCode",
"code": "D004155",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"alternateName": "Methylenebis(chloroaniline)",
"url": "https://questionsmedicales.fr/mesh/D008753",
"about": {
"@type": "MedicalCondition",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"code": {
"@type": "MedicalCode",
"code": "D008753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modafinil",
"alternateName": "Modafinil",
"url": "https://questionsmedicales.fr/mesh/D000077408",
"about": {
"@type": "MedicalCondition",
"name": "Modafinil",
"code": {
"@type": "MedicalCode",
"code": "D000077408",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"url": "https://questionsmedicales.fr/mesh/D009966",
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"alternateName": "Benzhydryl Compounds",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Loyd V Allen",
"url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen",
"affiliation": {
"@type": "Organization",
"name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com."
}
},
{
"@type": "Person",
"name": "Jonas Bresien",
"url": "https://questionsmedicales.fr/author/Jonas%20Bresien",
"affiliation": {
"@type": "Organization",
"name": "Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de."
}
},
{
"@type": "Person",
"name": "Jose M Goicoechea",
"url": "https://questionsmedicales.fr/author/Jose%20M%20Goicoechea",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Alexander Hinz",
"url": "https://questionsmedicales.fr/author/Alexander%20Hinz",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moritz T Scharnhölz",
"url": "https://questionsmedicales.fr/author/Moritz%20T%20Scharnh%C3%B6lz",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gene expression profile analyses to identify potential biomarkers for myopia.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35610360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02013-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Population-Specific gene expression profiles in prostate cancer: insights from Weighted Gene Co-expression Network Analysis (WGCNA).",
"datePublished": "2024-07-05",
"url": "https://questionsmedicales.fr/article/38970097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-024-03459-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of potential crucial genes and mechanisms associated with metastasis of medulloblastoma based on gene expression profile.",
"datePublished": "2022-10-10",
"url": "https://questionsmedicales.fr/article/36215435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01616412.2022.2132457"
}
},
{
"@type": "ScholarlyArticle",
"name": "RoPE: A robust profile likelihood method for differential gene expression analysis.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37042632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/gepi.22526"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive identification of GASA genes in sunflower and expression profiling in response to drought.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39402437",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12864-024-10860-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés benzhydryliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés benzhydryliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés benzhydryliques",
"description": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une surdose ?\nComment différencier les effets des composés benzhydryliques ?\nQuels signes cliniques sont associés à ces composés ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés benzhydryliques",
"description": "Quels sont les symptômes courants d'une exposition ?\nPeut-on avoir des réactions cutanées ?\nQuels effets neurologiques peuvent se manifester ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon la dose ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés benzhydryliques",
"description": "Comment prévenir l'exposition aux composés benzhydryliques ?\nY a-t-il des formations recommandées ?\nQuels sont les conseils de stockage sécuritaire ?\nComment sensibiliser le personnel aux risques ?\nQuelles sont les réglementations à suivre ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés benzhydryliques",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nComment gérer les symptômes neurologiques ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il envisager une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés benzhydryliques",
"description": "Quelles complications peuvent survenir après une exposition ?\nLes effets à long terme sont-ils possibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés benzhydryliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il le risque d'effets ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales affectent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests de laboratoire spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et urinaires peuvent détecter la présence de ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, somnolence et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment différencier les effets des composés benzhydryliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation clinique complète et l'historique des médicaments sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à ces composés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des anomalies neurologiques et des troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des maux de tête."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des réactions cutanées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et des démangeaisons peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets neurologiques peuvent se manifester ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la coordination et des convulsions peuvent se produire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés respiratoires et une respiration rapide peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux composés benzhydryliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection lors de la manipulation de ces substances."
}
},
{
"@type": "Question",
"name": "Y a-t-il des formations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la manipulation sécurisée des produits chimiques sont conseillées."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils de stockage sécuritaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Stocker dans des contenants étiquetés et dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des sessions d'information régulières sur les dangers des composés."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations à suivre ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les réglementations locales et nationales sur la manipulation des produits chimiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'administration de charbon actif et une surveillance médicale."
}
},
{
"@type": "Question",
"name": "Des antidotes spécifiques existent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les composés benzhydryliques."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les crises."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour aider à éliminer les toxines du corps."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et respiratoires peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les effets à long terme sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme sur la santé peuvent survenir après une exposition prolongée."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition et le cancer."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en respectant les mesures de sécurité et en évitant l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'effets ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition dans des environnements mal ventilés augmente le risque."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme et l'alcoolisme peuvent exacerber les effets des composés."
}
}
]
}
]
}
Increasing evidence suggests myopia is not a simple refractive error, many other factors might also be involved. Here, we assessed myopic and normal corneas' gene expression profiles to identify possi...
We obtained the expression profile of ten patients and seven normal control samples from the GSE112155 and GSE151631 datasets based on the Gene Expression Omnibus (GEO) database. We used the "limma" R...
We identified that the DEGs were significantly enriched in ultraviolet (UV) response, TNF-α signaling via NFκB, Angiogenesis, Myogenesis pathways, etc. We used 2095 genes to construct the co-expressio...
Our findings identified some markers that might detect diagnosis and treatment for myopia from cornea aspect. Future studies are warranted to verify the functional role of immune-related pathways in c...
This study investigates the genetic factors contributing to the disparity in prostate cancer incidence and progression among African American men (AAM) compared to European American men (EAM). The res...
Medulloblastoma is the most common malignant brain tumor in childhood. Although metastasis constitutes one of the poorest prognostic indicators in this disease, the mechanisms that drive metastasis ha...
Gene expression profile of GSE468 was downloaded from GEO database and was analyzed using limma R package. Function and enrichment analyses of DEGs were performed based on PANTHER database. PPI networ...
Nine upregulated genes and 34 downregulated genes were selected as DEGs. The upregulated genes were mainly enriched in molecular function and cell component, which mainly included protein binding and ...
Through the bioinformatics analysis of the gene microarray in GEO, we found some crucial genes and pathways associated with the metastasis of medulloblastoma....
Variation in RNA-Seq data creates modeling challenges for differential gene expression (DE) analysis. Statistical approaches address conventional small sample sizes and implement empirical Bayes or no...
Drought stress poses a critical threat to global crop yields and sustainable agriculture. The GASA genes are recognized for their pivotal role in stress tolerance and plant growth, but little is known...
In this study we examine the impact of cell confluency on gene expression. We focused on Argonaute (AGO) protein dynamics and associated gene and protein expression in HEK293, A375, and SHSY5Y cell li...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and has a poor prognosis. Identifying biomarkers based on molecular mechanisms is critical for early diagnosis, timely treatme...
MALAT1 expression levels were measured using RT-qPCR. The biological functions of MALAT1 in NSCLC were analyzed by cell counting, colony forming, wound-healing, and Transwell invasion assays. In addit...
Comparative analysis versus MALAT1 expression in MRC5 cells (a normal lung cell line) and the three NSCLC cell lines showed that MALAT1 expression was significantly higher in the NSCLC cells. MALAT1 k...
MALAT1 might function as an oncogene that enhances NSCLC cell survival, proliferation, colony formation, and invasion. RNA-seq and bioinformatic analyses resulted in the selection of five DEGs, PGAM1,...
Liver cirrhosis has been increasingly diagnosed at an early stage owing to the non-invasive diagnostic techniques. However, it is difficult to identify patients at high risk of disease progression. Sc...
RNA-sequencing (RNA-seq) is a versatile, high-throughput technology that is being widely employed for screening differentially expressed genes (DEGs) in various diseases. Echinococcosis, a globally di...
Sertoli cell-only syndrome (SCOS) is the most severe and common pathological type of non-obstructive azoospermia. The etiology of SCOS remains largely unknown to date despite a handful of studies repo...